APO Research
Talk to an analyst

APO RESEARCH · REPORT

Central Nervous System (CNS) Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Central Nervous System (CNS) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025191 pages

Choose your research edition.

Industry ResearchCentral Nervous System (CNS) Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Central Nervous System (CNS) Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Central Nervous System (CNS) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Central Nervous System (CNS) Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Central Nervous System (CNS) Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Central Nervous System (CNS) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Central Nervous System (CNS) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Central Nervous System (CNS) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Central Nervous System (CNS) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Central Nervous System (CNS) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Central Nervous System (CNS) Drug include Tekeda, Teva, Shanghai Fosun, Johnson & Johnson, Novartis AG, Roche, Eli Lilly, Jiangsu Nhwa Pharmaceutical Co., Ltd. and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Central Nervous System (CNS) Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Central Nervous System (CNS) Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Central Nervous System (CNS) Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Central Nervous System (CNS) Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Central Nervous System (CNS) Drug Segment by Company

Tekeda

Teva

Shanghai Fosun

Johnson & Johnson

Novartis AG

Roche

Eli Lilly

Jiangsu Nhwa Pharmaceutical Co., Ltd.

Pfizer Inc

GSK

UCB

Otsuka Pharmaceutical Co., Ltd

Boehringer Ingelheim

Biogen Inc

Central Nervous System (CNS) Drug Segment by Type

Prescription Drugs

OTC

Central Nervous System (CNS) Drug Segment by Application

Epilepsy Drugs

MS Therapeutics

Antipsychotic Drugs

Depression Drugs

Others

Central Nervous System (CNS) Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Central Nervous System (CNS) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Central Nervous System (CNS) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Central Nervous System (CNS) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Central Nervous System (CNS) Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Central Nervous System (CNS) Drug industry.

Chapter 3: Detailed analysis of Central Nervous System (CNS) Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Central Nervous System (CNS) Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Prescription Drugs Table 3. Key Players of OTC Table 4. Global Central Nervous System (CNS) Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Epilepsy Drugs Table 6. Key Players of MS Therapeutics Table 7. Key Players of Antipsychotic Drugs Table 8. Key Players of Depression Drugs Table 9. Key Players of Others Table 10. Global Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Central Nervous System (CNS) Drug Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Central Nervous System (CNS) Drug Market Share by Region (2021-2026) Table 13. Global Central Nervous System (CNS) Drug Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Central Nervous System (CNS) Drug Market Share by Region (2027-2032) Table 15. Central Nervous System (CNS) Drug Industry Trends Table 16. Central Nervous System (CNS) Drug Industry Drivers Table 17. Central Nervous System (CNS) Drug Industry Opportunities and Challenges Table 18. Central Nervous System (CNS) Drug Industry Restraints Table 19. Global Central Nervous System (CNS) Drug Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Central Nervous System (CNS) Drug Revenue Market Share by Company (2021-2026) Table 21. Global Central Nervous System (CNS) Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Central Nervous System (CNS) Drug Key Company Head Office and Area Served Table 23. Global Central Nervous System (CNS) Drug Company, Product Type & Application Table 24. Global Central Nervous System (CNS) Drug Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Central Nervous System (CNS) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Central Nervous System (CNS) Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Central Nervous System (CNS) Drug Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Central Nervous System (CNS) Drug Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2021-2026) Table 31. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2027-2032) Table 32. Global Central Nervous System (CNS) Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Central Nervous System (CNS) Drug Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Central Nervous System (CNS) Drug Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2021-2026) Table 36. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2027-2032) Table 37. Tekeda Company Information Table 38. Tekeda Business Overview Table 39. Tekeda Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Tekeda Central Nervous System (CNS) Drug Product Portfolio Table 41. Tekeda Recent Development Table 42. Teva Company Information Table 43. Teva Business Overview Table 44. Teva Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Teva Central Nervous System (CNS) Drug Product Portfolio Table 46. Teva Recent Development Table 47. Shanghai Fosun Company Information Table 48. Shanghai Fosun Business Overview Table 49. Shanghai Fosun Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Shanghai Fosun Central Nervous System (CNS) Drug Product Portfolio Table 51. Shanghai Fosun Recent Development Table 52. Johnson & Johnson Company Information Table 53. Johnson & Johnson Business Overview Table 54. Johnson & Johnson Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Johnson & Johnson Central Nervous System (CNS) Drug Product Portfolio Table 56. Johnson & Johnson Recent Development Table 57. Novartis AG Company Information Table 58. Novartis AG Business Overview Table 59. Novartis AG Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Novartis AG Central Nervous System (CNS) Drug Product Portfolio Table 61. Novartis AG Recent Development Table 62. Roche Company Information Table 63. Roche Business Overview Table 64. Roche Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Roche Central Nervous System (CNS) Drug Product Portfolio Table 66. Roche Recent Development Table 67. Eli Lilly Company Information Table 68. Eli Lilly Business Overview Table 69. Eli Lilly Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Eli Lilly Central Nervous System (CNS) Drug Product Portfolio Table 71. Eli Lilly Recent Development Table 72. Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Information Table 73. Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview Table 74. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Portfolio Table 76. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Development Table 77. Pfizer Inc Company Information Table 78. Pfizer Inc Business Overview Table 79. Pfizer Inc Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Pfizer Inc Central Nervous System (CNS) Drug Product Portfolio Table 81. Pfizer Inc Recent Development Table 82. GSK Company Information Table 83. GSK Business Overview Table 84. GSK Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. GSK Central Nervous System (CNS) Drug Product Portfolio Table 86. GSK Recent Development Table 87. UCB Company Information Table 88. UCB Business Overview Table 89. UCB Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. UCB Central Nervous System (CNS) Drug Product Portfolio Table 91. UCB Recent Development Table 92. Otsuka Pharmaceutical Co., Ltd Company Information Table 93. Otsuka Pharmaceutical Co., Ltd Business Overview Table 94. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Portfolio Table 96. Otsuka Pharmaceutical Co., Ltd Recent Development Table 97. Boehringer Ingelheim Company Information Table 98. Boehringer Ingelheim Business Overview Table 99. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Boehringer Ingelheim Central Nervous System (CNS) Drug Product Portfolio Table 101. Boehringer Ingelheim Recent Development Table 102. Biogen Inc Company Information Table 103. Biogen Inc Business Overview Table 104. Biogen Inc Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Biogen Inc Central Nervous System (CNS) Drug Product Portfolio Table 106. Biogen Inc Recent Development Table 107. North America Central Nervous System (CNS) Drug Market Size by Type (2021-2026) & (US$ Million) Table 108. North America Central Nervous System (CNS) Drug Market Size by Type (2027-2032) & (US$ Million) Table 109. North America Central Nervous System (CNS) Drug Market Size by Application (2021-2026) & (US$ Million) Table 110. North America Central Nervous System (CNS) Drug Market Size by Application (2027-2032) & (US$ Million) Table 111. North America Central Nervous System (CNS) Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Central Nervous System (CNS) Drug Market Size by Country (2021-2026) Table 113. North America Central Nervous System (CNS) Drug Market Size by Country (2027-2032) Table 114. Europe Central Nervous System (CNS) Drug Market Size by Type (2021-2026) & (US$ Million) Table 115. Europe Central Nervous System (CNS) Drug Market Size by Type (2027-2032) & (US$ Million) Table 116. Europe Central Nervous System (CNS) Drug Market Size by Application (2021-2026) & (US$ Million) Table 117. Europe Central Nervous System (CNS) Drug Market Size by Application (2027-2032) & (US$ Million) Table 118. Europe Central Nervous System (CNS) Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Central Nervous System (CNS) Drug Market Size by Country (2021-2026) Table 120. Europe Central Nervous System (CNS) Drug Market Size by Country (2027-2032) Table 121. China Central Nervous System (CNS) Drug Market Size by Type (2021-2026) & (US$ Million) Table 122. China Central Nervous System (CNS) Drug Market Size by Type (2027-2032) & (US$ Million) Table 123. China Central Nervous System (CNS) Drug Market Size by Application (2021-2026) & (US$ Million) Table 124. China Central Nervous System (CNS) Drug Market Size by Application (2027-2032) & (US$ Million) Table 125. Asia Central Nervous System (CNS) Drug Market Size by Type (2021-2026) & (US$ Million) Table 126. Asia Central Nervous System (CNS) Drug Market Size by Type (2027-2032) & (US$ Million) Table 127. Asia Central Nervous System (CNS) Drug Market Size by Application (2021-2026) & (US$ Million) Table 128. Asia Central Nervous System (CNS) Drug Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Central Nervous System (CNS) Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Central Nervous System (CNS) Drug Market Size by Country (2021-2026) Table 131. Asia Central Nervous System (CNS) Drug Market Size by Country (2027-2032) Table 132. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2021-2026) Table 138. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Central Nervous System (CNS) Drug Product Image Figure 2. Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Central Nervous System (CNS) Drug Market Share by Type: 2025 VS 2032 Figure 4. Prescription Drugs Image Figure 5. OTC Image Figure 6. Global Central Nervous System (CNS) Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Central Nervous System (CNS) Drug Market Share by Application: 2025 VS 2032 Figure 8. Epilepsy Drugs Image Figure 9. MS Therapeutics Image Figure 10. Antipsychotic Drugs Image Figure 11. Depression Drugs Image Figure 12. Others Image Figure 13. Global Central Nervous System (CNS) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 15. Global Central Nervous System (CNS) Drug Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Central Nervous System (CNS) Drug Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Central Nervous System (CNS) Drug Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Central Nervous System (CNS) Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2021-2032) Figure 22. Global Central Nervous System (CNS) Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 25. North America Central Nervous System (CNS) Drug Market Share by Type (2021-2032) Figure 26. North America Central Nervous System (CNS) Drug Market Share by Application (2021-2032) Figure 27. North America Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 28. United States Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 29. Canada Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Central Nervous System (CNS) Drug Market Share by Type (2021-2032) Figure 33. Europe Central Nervous System (CNS) Drug Market Share by Application (2021-2032) Figure 34. Europe Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 35. Germany Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 36. France Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 38. Italy Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 39. Russia Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Central Nervous System (CNS) Drug Market Share by Type (2021-2032) Figure 43. China Central Nervous System (CNS) Drug Market Share by Application (2021-2032) Figure 44. Asia Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 45. Asia Central Nervous System (CNS) Drug Market Share by Type (2021-2032) Figure 46. Asia Central Nervous System (CNS) Drug Market Share by Application (2021-2032) Figure 47. Asia Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 48. Japan Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 52. India Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 53. Australia Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 58. Brazil Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 63. UAE Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 65. Chile Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drugs
  • OTC
Applications
  • Epilepsy Drugs
  • MS Therapeutics
  • Antipsychotic Drugs
  • Depression Drugs
  • Others
Companies covered
  • Tekeda
  • Teva
  • Shanghai Fosun
  • Johnson & Johnson
  • Novartis AG
  • Roche
  • Eli Lilly
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Pfizer Inc
  • GSK
  • UCB
  • Otsuka Pharmaceutical Co., Ltd
  • Boehringer Ingelheim
  • Biogen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Drugs
  5. 1.2.3 OTC
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Central Nervous System (CNS) Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Epilepsy Drugs
  9. 1.3.3 MS Therapeutics
  10. 1.3.4 Antipsychotic Drugs
  11. 1.3.5 Depression Drugs
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Central Nervous System (CNS) Drug Growth Trends by Region
  15. 1.5.1 Global Central Nervous System (CNS) Drug Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Central Nervous System (CNS) Drug Market Size by Region (2021-2026)
  17. 1.5.3 Central Nervous System (CNS) Drug Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Central Nervous System (CNS) Drug Market Dynamics
  1. 2.1 Central Nervous System (CNS) Drug Industry Trends
  2. 2.2 Central Nervous System (CNS) Drug Industry Drivers
  3. 2.3 Central Nervous System (CNS) Drug Industry Opportunities and Challenges
  4. 2.4 Central Nervous System (CNS) Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Central Nervous System (CNS) Drug Revenue by Company (2021-2026)
  2. 3.2 Global Central Nervous System (CNS) Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Central Nervous System (CNS) Drug Key Company Head office and Area Served
  4. 3.4 Global Central Nervous System (CNS) Drug Company, Product Type & Application
  5. 3.5 Global Central Nervous System (CNS) Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Central Nervous System (CNS) Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Central Nervous System (CNS) Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Central Nervous System (CNS) Drug Tier 1, Tier 2, and Tier 3
4 Central Nervous System (CNS) Drug Market by Type
  1. 4.1 Global Central Nervous System (CNS) Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Central Nervous System (CNS) Drug Market Size by Type (2021-2032)
  3. 4.3 Global Central Nervous System (CNS) Drug Market Size Share by Type (2021-2032)
5 Central Nervous System (CNS) Drug Market by Application
  1. 5.1 Global Central Nervous System (CNS) Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Central Nervous System (CNS) Drug Market Size by Application (2021-2032)
  3. 5.3 Global Central Nervous System (CNS) Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Tekeda
  2. 6.1.1 Tekeda Company Information
  3. 6.1.2 Tekeda Business Overview
  4. 6.1.3 Tekeda Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Tekeda Central Nervous System (CNS) Drug Product Portfolio
  6. 6.1.5 Tekeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Central Nervous System (CNS) Drug Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Shanghai Fosun
  14. 6.3.1 Shanghai Fosun Company Information
  15. 6.3.2 Shanghai Fosun Business Overview
  16. 6.3.3 Shanghai Fosun Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shanghai Fosun Central Nervous System (CNS) Drug Product Portfolio
  18. 6.3.5 Shanghai Fosun Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Johnson & Johnson Central Nervous System (CNS) Drug Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis AG
  26. 6.5.1 Novartis AG Company Information
  27. 6.5.2 Novartis AG Business Overview
  28. 6.5.3 Novartis AG Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis AG Central Nervous System (CNS) Drug Product Portfolio
  30. 6.5.5 Novartis AG Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Roche Central Nervous System (CNS) Drug Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eli Lilly Central Nervous System (CNS) Drug Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Jiangsu Nhwa Pharmaceutical Co., Ltd.
  44. 6.8.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Portfolio
  48. 6.8.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Pfizer Inc
  50. 6.9.1 Pfizer Inc Company Information
  51. 6.9.2 Pfizer Inc Business Overview
  52. 6.9.3 Pfizer Inc Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pfizer Inc Central Nervous System (CNS) Drug Product Portfolio
  54. 6.9.5 Pfizer Inc Recent Developments
  55. 6.10 GSK
  56. 6.10.1 GSK Company Information
  57. 6.10.2 GSK Business Overview
  58. 6.10.3 GSK Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GSK Central Nervous System (CNS) Drug Product Portfolio
  60. 6.10.5 GSK Recent Developments
  61. 6.11 UCB
  62. 6.11.1 UCB Company Information
  63. 6.11.2 UCB Business Overview
  64. 6.11.3 UCB Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 UCB Central Nervous System (CNS) Drug Product Portfolio
  66. 6.11.5 UCB Recent Developments
  67. 6.12 Otsuka Pharmaceutical Co., Ltd
  68. 6.12.1 Otsuka Pharmaceutical Co., Ltd Company Information
  69. 6.12.2 Otsuka Pharmaceutical Co., Ltd Business Overview
  70. 6.12.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Portfolio
  72. 6.12.5 Otsuka Pharmaceutical Co., Ltd Recent Developments
  73. 6.13 Boehringer Ingelheim
  74. 6.13.1 Boehringer Ingelheim Company Information
  75. 6.13.2 Boehringer Ingelheim Business Overview
  76. 6.13.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Boehringer Ingelheim Central Nervous System (CNS) Drug Product Portfolio
  78. 6.13.5 Boehringer Ingelheim Recent Developments
  79. 6.14 Biogen Inc
  80. 6.14.1 Biogen Inc Company Information
  81. 6.14.2 Biogen Inc Business Overview
  82. 6.14.3 Biogen Inc Central Nervous System (CNS) Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Biogen Inc Central Nervous System (CNS) Drug Product Portfolio
  84. 6.14.5 Biogen Inc Recent Developments
7 North America
  1. 7.1 North America Central Nervous System (CNS) Drug Market Size (2021-2032)
  2. 7.2 North America Central Nervous System (CNS) Drug Market Size by Type
  3. 7.2.1 North America Central Nervous System (CNS) Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Central Nervous System (CNS) Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Central Nervous System (CNS) Drug Market Share by Type (2021-2032)
  6. 7.3 North America Central Nervous System (CNS) Drug Market Size by Application
  7. 7.3.1 North America Central Nervous System (CNS) Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Central Nervous System (CNS) Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Central Nervous System (CNS) Drug Market Share by Application (2021-2032)
  10. 7.4 North America Central Nervous System (CNS) Drug Market Size by Country
  11. 7.4.1 North America Central Nervous System (CNS) Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Central Nervous System (CNS) Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Central Nervous System (CNS) Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Central Nervous System (CNS) Drug Market Size (2021-2032)
  2. 8.2 Europe Central Nervous System (CNS) Drug Market Size by Type
  3. 8.2.1 Europe Central Nervous System (CNS) Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Central Nervous System (CNS) Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Central Nervous System (CNS) Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Central Nervous System (CNS) Drug Market Size by Application
  7. 8.3.1 Europe Central Nervous System (CNS) Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Central Nervous System (CNS) Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Central Nervous System (CNS) Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Central Nervous System (CNS) Drug Market Size by Country
  11. 8.4.1 Europe Central Nervous System (CNS) Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Central Nervous System (CNS) Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Central Nervous System (CNS) Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Central Nervous System (CNS) Drug Market Size (2021-2032)
  2. 9.2 China Central Nervous System (CNS) Drug Market Size by Type
  3. 9.2.1 China Central Nervous System (CNS) Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Central Nervous System (CNS) Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Central Nervous System (CNS) Drug Market Share by Type (2021-2032)
  6. 9.3 China Central Nervous System (CNS) Drug Market Size by Application
  7. 9.3.1 China Central Nervous System (CNS) Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Central Nervous System (CNS) Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Central Nervous System (CNS) Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Central Nervous System (CNS) Drug Market Size (2021-2032)
  2. 10.2 Asia Central Nervous System (CNS) Drug Market Size by Type
  3. 10.2.1 Asia Central Nervous System (CNS) Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Central Nervous System (CNS) Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Central Nervous System (CNS) Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Central Nervous System (CNS) Drug Market Size by Application
  7. 10.3.1 Asia Central Nervous System (CNS) Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Central Nervous System (CNS) Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Central Nervous System (CNS) Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Central Nervous System (CNS) Drug Market Size by Country
  11. 10.4.1 Asia Central Nervous System (CNS) Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Central Nervous System (CNS) Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Central Nervous System (CNS) Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst